both in affected skin and in non-affected skin (5) . Mainly glucocorticosteroids were used in topical and systemic atopy treatments because of their potent antiinflammatory effects (8) , unfortunately with strong side effects (1) . Other steroid hormones have also been reported to have supportive or detrimental effects on atopy (2, 12) .
In this study we aimed to investigate how the levels of several steroids are altered in the plasma of AD-patients compared to healthy volunteers.
Plasma samples of 20 healthy volunteers and 20 AD-patients were collected at comparable day time, between 8-10 a.m. in order to minimise the influence of circadian regulation of hormones. In addition, AD-patients were not under treatment of oral glucocorticoids and topical corticosteroids for at least 5 days prior to blood sampling. SCORAD (SCORe Atopic Dermatitis) index of AD-patients was 35.2 (range 13-64) (11) . The sterroid hormones were quantified with the commercially available AbsoluteIDQ® Stero17 kit from Biocrates that comprises 16 endogenous steroids (Table 1) . 200-450 µL of human plasma were used for analysis. The HPLC-MS/MS analysis in multiple reaction monitoring mode (MRM) using a SCIEX API 4000 QTrap was preceeded by a sample preparation procedure based on solid phase extraction technique in a 96 well plate-format fundamental for pre-cleaning and preconcentration of the target steroid hormones. For quantification of the steroid compounds, 7-point external calibration curves and 13 isotope-labeled internal standards were used.
Steroid hormones can be divided into five different categories; a) mineralocorticosteroids, b) glucocorticosteroids, c) androgens, d) estrogens and e) This article is protected by copyright. All rights reserved.
progestagens. Mineralocorticoid, progestagen levels remained mainly unchanged in AD-patients vs healthy volunteers (table 1). From the glucocorticoids the level of cortisone was significantly increased (H: 66.2 ± 17.5 ng/ml, D: 79.7 ± 21.5 ng/ml, p=0.04) while the bioactive metabolite cortisol also displayed a slight tendency of increase (H: 327 ± 154 ng/ml, D: 407 ± 209 ng/ml, p=0.19). The plasma level of the androgen DHEAS was significantly decreased (H: 8857 ± 3918 ng/ml to D: 5187 ± 3362 ng/ml) in AD-patients. Regarding the levels of the estrogen estrone a tendency of decreased levels could be found in AD-patients (H: 0.33 ± 0.14 ng/ml, D: 0.25 ± 0.11 ng/ml, p=0.07). When comparing steroid concentrations in healthy male (HM) volunteers and male AD-patients (DM) (table 2A), the mineralocorticoid, estrogen and progestagen levels were comparable in HM vs DM, while for the androgen DHEAS levels (HM: 10141 ± 4758 ng/ml, DM: 5186 ± 3612 ng/ml) were significantly lower and DHEA levels just displayed a lower tendency (HM: 22.6 ± 7.4 ng/ml, DM: 15.4 ± 7.5 ng/ml, p=0.08) in the plasma of DM. Levels of the steroids mineralocorticoid, estrogens and progestagen in healthy female volunteers (HF) and female AD-patients (DF) (table 2B) were comparable between HF and DF, while the androgen DHEAS levels (HW: 8166 ± 3305 ng/ml, DF: 5188 ± 3323 ng/ml) were significantly lower in plasma of female AD-patients. The glucocorticoid levels of 11-deoxycortisol (HW: 0.47 ± 0.26 ng/ml, DF: 1.16 ± 0.81 ng/ml) were significantly higher and cortisone levels displayed just a higher tendency (HF: 66.0 ± 17.3 ng/ml, DF: 79.5 ± 17.4 ng/ml, p=0.07) in female AD-patients. Steroid concentration of DHT (M: 0.82 ± 0.41 ng/ml, F: 0.56 ± 0.29 ng/ml) and testosterone (M: 11.1 ± 8.39 ng/ml, F: 3.15 ± 4.94 ng/ml) were significantly lower in female individuals (F) vs male individuals (M) (table 2C), while ethiocolanolone levels (M: 0.37 ± 0.17 ng/ml, F: 0.58 ± 0.39 ng/ml) were significantly lower in male individuals. Mineralocorticoid, glucocorticoid, estrogen and progestagen levels were surprisingly comparable in woman and man.
In summary in this study we determined that 2 out of 16 steroids were significantly different in healthy volunteers vs AD-patients. Cortisone, which is higher in ADpatients plasma, is a direct precursor of the bioactive corticosteroid cortisol, which just displays a higher tendency and is known for its potent anti-inflammatory effects This article is protected by copyright. All rights reserved. (8) . These increased levels of corticosteroids levels in AD-patients plasma may mean that there is an increased formation of anti-inflammatory steroids as a feedback mechanism present in AD-patients which comparably has also been found for precursors of anti-inflammatory eicosanoids (11) . In addition a tendency of reduced levels of the anti-inflammatory ERα ligand estrone (6) was found in AD-patients.
DHEA is a precursor of testosterone, its levels just display a lower tendency in male AD-patients, while its sulfonation metabolite DHEAS is lower in male and female ADpatients and decreased DHEAS levels were previously found in atopic allergy and chronic urticaria (8) (9) . In acne patients increased levels of DHEAS were found (3) and further impaired sebum secretion may be the outcome of this decreased DHEAS levels and may even could contribute to AD-phenotype (4). Furthermore DHEA(S) application affects production and secretion of Th1 and Th2 cytokines showing an immunomodulatory effect during allergic sensitization and allergic responses (9-10).
The DHEA sulfonation is mediated by dehydroepiandrosterone sulfotransferase (SULT2A1), which is a direct vitamin D receptor target gene (7) and thereby suggests reduced vitamin D-signaling during atopy (13).
We conclude that altered steroid levels in the plasma of AD-patients indicate altered vitamin D signaling (based on reduced DHEA sulfonation) and increased feedback for anti-inflammatory signaling (increased levels of cortisone) present in AD-patients. This article is protected by copyright. All rights reserved. in healthy volunteers (H, n=20) and AD-patients (D, n=20) 
) healthy male volunteers (HM) vs male AD-patients (DM), (B.) healthy female volunteers (HF) vs female AD-patients (DF) as well as (C.) female individuals (F, n=24) vs male individuals (M, n=16). SD -standard deviation.
A. Steroid concentrations in healthy male volunteers (HM, n=7) and male AD-patients (DM, n=9) in ng/ml. 
